Same Drug Class

Methotrexate vs Nivolumab

Methotrexate vs Nivolumab: Overview

This comparison examines the pharmacological differences between Methotrexate and Nivolumab.

Mechanism of Action

Methotrexate: Dihydrofolate reductase inhibitor.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Methotrexate β€” 3-10 hours; Nivolumab β€” 27 days.

Chemical Properties

Molecular Formula: Methotrexate β€” C20H22N8O5.

Molecular Weight: Methotrexate β€” 454.4400 g/mol.

Type: Methotrexate β€” Small molecule; Nivolumab β€” Antibody.